News by community

09.01.2017 Abionic Receives CE Mark for Most Rapid Sepsis and Iron Deficiency Point of Care Diagnostics

LAUSANNE, Switzerland–(BUSINESS WIRE)–Abionic SA, a developer of disrupter nanotechnology based point-of-care diagnostic solutions, announced today the receipt of CE Mark (Conformité Européenne) for two novel tests using its easy to use testing platform, abioSCOPE. The CE Mark allows Abionic to commercialize its tests for sepsis risk assessment and management (PSP Test) and iron deficiency throughout the European Union.

More information

back